A LinkedIn post from All G describes the company’s participation in the PCHi 2026 Personal Care and Homecare Ingredients event in China and its engagement with beauty and skincare innovators. The post suggests that industry discussions at the event emphasized a shift toward high‑performance, biologically active skincare ingredients supported by robust scientific evidence.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
According to the post, All G positions its precision‑fermented protein platform, including its LFX lactoferrin, as aligned with this trend, highlighting attributes such as a clean and consistent profile, scalable and animal‑free production, and preclinical data indicating enhanced functional potential across key pathways. The post indicates that PCHi served as a venue to deepen partner dialogue in the region, which could imply an effort to expand commercial relationships and explore differentiated formulations in the Chinese and broader Asian beauty markets.
For investors, the focus on precision fermentation and biologically active ingredients may signal All G’s intent to target higher‑value segments within the beauty and personal care supply chain, where scientific validation can support premium pricing and defensible positioning. If the company can convert regional interest and preclinical results into commercial supply agreements, this approach could enhance revenue visibility and strengthen its competitive standing in the emerging area of biotech‑enabled skincare ingredients.